Valuation: Qlife Holding AB

Market Cap 30.14M 3.03M 2.71M 2.51M 2.27M 4.25M 288M 4.31M 11.92M 151M 11.36M 11.12M 477M P/E 2024
-0.26x
P/E 2025 -1.73x
Enterprise Value 43.17M 4.34M 3.88M 3.59M 3.25M 6.08M 413M 6.18M 17.08M 216M 16.27M 15.93M 683M EV / Sales 2024
222x
EV / Sales 2025 178x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day-5.78%
1 week-7.28%
Current month-25.43%
1 month-29.36%
3 months-47.48%
6 months-45.05%
Current year-63.24%
1 week 0.85
Extreme 0.85
1.56
1 month 0.85
Extreme 0.85
1.67
Current year 0.85
Extreme 0.85
3.09
1 year 0.85
Extreme 0.85
3.8
3 years 0.85
Extreme 0.85
179
5 years 0.85
Extreme 0.85
73,000
10 years 0.85
Extreme 0.85
120,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2019
Chief Executive Officer 59 11/10/2019
Director of Finance/CFO 60 01/11/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2021
Director/Board Member 52 01/01/2023
Chairman 61 21/03/2025
Date Insider Type Main position Quantity % Market Cap. Importance
14/6/23 Free

Chief Executive Officer

12,697,080 2.1166%
14/6/23
Qlife ApS
OthersCompany 40,630,656 6.7731%
13/6/23 Free

Chief Financial Officer

5,078,832 0.8466%
Change 5-day change 1-year change 3-year change Capi.($)
-5.78%-7.28%-52.33%-98.34% 3.22M
+0.60%+0.11%-18.09%+10.85% 179B
-0.40%+2.15%-20.68%+17.70% 118B
-0.73%+1.91%+0.44%+34.35% 117B
-3.42%+15.09%-44.71%+5.61% 93.26B
-0.25%-2.90%-1.76%+75.04% 63.16B
+0.04%+1.79%+13.52%+75.53% 55.68B
-1.53%+2.55%+4.58%-23.04% 54.18B
+1.62%+2.46%-12.04%+43.28% 44.15B
+0.03%+6.23%-4.20%-7.53% 33.95B
Average -0.97%+2.92%-13.53%+13.35% 75.84B
Weighted average by Cap. -0.48%+3.05%-12.64%+23.63%

Financials

2024 2025
Net sales 50K 5.02K 4.49K 4.16K 3.76K 7.04K 478K 7.16K 19.78K 250K 18.85K 18.45K 791K 324K 32.55K 29.1K 26.92K 24.38K 45.63K 3.1M 46.37K 128K 1.62M 122K 120K 5.13M
Net income -55.92M -5.62M -5.02M -4.65M -4.21M -7.87M -534M -8M -22.12M -280M -21.08M -20.63M -885M -20.56M -2.07M -1.85M -1.71M -1.55M -2.9M -196M -2.94M -8.13M -103M -7.75M -7.58M -325M
Net Debt 5.98M 601K 537K 497K 450K 843K 57.19M 856K 2.37M 29.91M 2.26M 2.21M 94.71M 13.02M 1.31M 1.17M 1.08M 980K 1.83M 124M 1.86M 5.15M 65.1M 4.91M 4.8M 206M
Projected Income Statement - Annual - Qlife Holding AB
Logo Qlife Holding AB
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Employees
2
Date Price Change Volume
27/10/26 SEK 1.044 -5.78% 55,545
23/10/26 SEK 1.108 +19.27% 415,408
22/10/26 SEK 0.9290 -7.10% 81,829
21/10/26 SEK 1.000 -9.75% 94,426
20/10/26 SEK 1.108 -1.60% 101,437

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Qlife Holding AB
  1. Stock Market
  2. Stocks
  3. QLIFE Stock